Hemenway Trust Hemenway Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309K Hold
11,000
0.02% 103
2025
Q4
$274K Hold
11,000
0.02% 105
2025
Q3
$280K Sell
11,000
-1,000
-8% -$24.7K 0.02% 102
2025
Q2
$291K Hold
12,000
0.02% 97
2025
Q1
$304K Sell
12,000
-250
-2% -$6.54K 0.02% 98
2024
Q4
$325K Sell
12,250
-969
-7% -$26.3K 0.03% 95
2024
Q3
$383K Sell
13,219
-2,631
-17% -$76.8K 0.03% 97
2024
Q2
$443K Sell
15,850
-4,875
-24% -$134K 0.04% 91
2024
Q1
$575K Sell
20,725
-1,275
-6% -$35.4K 0.05% 81
2023
Q4
$633K Buy
22,000
+125
+0.6% +$3.78K 0.06% 76
2023
Q3
$726K Sell
21,875
-1,375
-6% -$48.6K 0.08% 74
2023
Q2
$853K Hold
23,250
0.08% 70
2023
Q1
$949K Sell
23,250
-3,750
-14% -$162K 0.1% 70
2022
Q4
$1.38M Sell
27,000
-750
-3% -$36K 0.15% 62
2022
Q3
$1.21M Buy
27,750
+2,668
+11% +$130K 0.14% 63
2022
Q2
$1.31M Buy
25,082
+1,000
+4% +$51K 0.15% 61
2022
Q1
$1.25M Hold
24,082
0.12% 63
2021
Q4
$1.42M Buy
24,082
+990
+4% +$49.1K 0.13% 61
2021
Q3
$993K Sell
23,092
-240
-1% -$10.6K 0.1% 69
2021
Q2
$914K Buy
23,332
+1,571
+7% +$61.1K 0.09% 72
2021
Q1
$788K Sell
21,761
-132
-0.6% -$4.69K 0.09% 73
2020
Q4
$806K Sell
21,893
-412
-2% -$15.1K 0.09% 76
2020
Q3
$777K Sell
22,305
-87
-0.4% -$3.05K 0.1% 71
2020
Q2
$695K Buy
22,392
+4
+0% +$136 0.1% 72
2020
Q1
$693K Sell
22,388
-376
-2% -$12.8K 0.12% 71
2019
Q4
$846K Buy
22,764
+11,851
+109% +$422K 0.12% 69
2019
Q3
$372K Buy
10,913
+198
+2% +$7.2K 0.06% 99
2019
Q2
$440K Sell
10,715
-1,154
-10% -$45.8K 0.07% 89
2019
Q1
$478K Sell
11,869
-770
-6% -$30.8K 0.08% 87
2018
Q4
$523K Sell
12,639
-3,492
-22% -$145K 0.11% 77
2018
Q3
$674K Buy
16,131
+1,039
+7% +$40K 0.11% 79
2018
Q2
$519K Sell
15,092
-1,006
-6% -$34.4K 0.1% 85
2018
Q1
$542K Sell
16,098
-3,526
-18% -$121K 0.1% 87
2017
Q4
$674K Sell
19,624
-4,174
-18% -$142K 0.13% 78
2017
Q3
$806K Sell
23,798
-343
-1% -$11K 0.17% 68
2017
Q2
$769K Hold
24,141
0.17% 70
2017
Q1
$784K Sell
24,141
-126
-0.5% -$3.97K 0.18% 70
2016
Q4
$748K Buy
24,267
+1,792
+8% +$54.7K 0.19% 71
2016
Q3
$722K Hold
22,475
0.18% 73
2016
Q2
$751K Sell
22,475
-454
-2% -$14.5K 0.2% 69
2016
Q1
$645K Buy
22,929
+633
+3% +$18.1K 0.17% 73
2015
Q4
$683K Sell
22,296
-2,875
-11% -$90.4K 0.18% 76
2015
Q3
$750K Sell
25,171
-843
-3% -$27K 0.21% 74
2015
Q2
$828K Sell
26,014
-3,281
-11% -$107K 0.21% 75
2015
Q1
$967K Buy
29,295
+10,495
+56% +$334K 0.25% 68
2014
Q4
$556K Buy
18,800
+696
+4% +$20K 0.17% 77
2014
Q3
$508K Hold
18,104
0.16% 79
2014
Q2
$510K Buy
18,104
+307
+2% +$8.75K 0.15% 83
2014
Q1
$542K Buy
17,797
+603
+4% +$18K 0.17% 77
2013
Q4
$500K Buy
17,194
+4,658
+37% +$136K 0.16% 81
2013
Q3
$342K Buy
12,536
+11,166
+815% +$304K 0.13% 89
2013
Q2
$36K Buy
+1,370
New +$37.9K 0.02% 133

Other funds holding PFE

Hemenway Trust Hemenway Trust's PFE Position: Q1 2026 in Review

Hemenway Trust Hemenway Trust held its Pfizer (PFE) position steady in Q1 2026 at 11,000 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #103.

Hemenway Trust Hemenway Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.42M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hemenway Trust Hemenway Trust held 11,000 shares of Pfizer worth $309K as of Q1 2026.
  • Hemenway Trust Hemenway Trust left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.02% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #103 holding.
  • Hemenway Trust Hemenway Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Hemenway Trust Hemenway Trust's Pfizer position peaked at $1.42M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.